Advertisement
UK markets close in 1 hour 37 minutes

  • FTSE 100

    8,049.50
    +9.12 (+0.11%)
     

  • FTSE 250

    19,569.79
    -149.58 (-0.76%)
     

  • AIM

    752.86
    -1.83 (-0.24%)
     

  • GBP/EUR

    1.1656
    +0.0011 (+0.09%)
     

  • GBP/USD

    1.2467
    +0.0004 (+0.03%)
     

  • Bitcoin GBP

    50,836.71
    -2,241.60 (-4.22%)
     

  • CMC Crypto 200

    1,368.15
    -14.42 (-1.04%)
     

  • S&P 500

    4,997.26
    -74.37 (-1.47%)
     

  • DOW

    37,812.21
    -648.71 (-1.69%)
     

  • CRUDE OIL

    82.82
    +0.01 (+0.01%)
     

  • GOLD FUTURES

    2,335.30
    -3.10 (-0.13%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     

  • DAX

    17,834.15
    -254.55 (-1.41%)
     

  • CAC 40

    7,966.14
    -125.72 (-1.55%)
     
Stocks:

Trending tickers

Microsoft, Alphabet, Anglo American, IBM, Astrazeneca, Unilever and Sainsbury's

BUZZ-OptimizeRX Corp: Falls as WPP cashes out

Reuters - UK Focus

(Updates, adds pricing details)

** OptimizeRX down ~16 pct at $9.77 premarket as top investor WPP Plc (Frankfurt: A1J2BZ - news) divests its ~18 pct stake in the digital health messaging firm

** OPRX among biggest pct losers across U.S. markets before the bell

** Co prices 2.1 mln share secondary offering by WPP (Swiss: OXWPP.SW - news) subsidiary at $10, ~14 pct discount to OPRX last sale on Mon

** WPP had made "strategic investment" in OPRX in Sept 2015 and in Mar 2018, according to prospectus filing

** OPRX has 7.2 mln shares of free float (Refinitiv data); offering represents more than 40 days of worth of trading volume

** Stock has risen 146 pct this year, following 94 pct gain in 2017